How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

One previously unreported SpaceX investor has ties to Chinese military contractors. The information was revealed only after ProPublica went to court to obtain it. The United States is requiring access ...

Lebanon said that Israeli air strikes killed at least 16 people in the south of the country, just hours after a ceasefire was supposed to begin. An Israeli military official said Israel had responded ...

Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026. Analysts expect potential upside from rare diseases.